• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高亲和力瘦素受体存在于源自对照和骨质疏松症供体的人间充质干细胞(MSC)中。

High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors.

作者信息

Hess Rodrigo, Pino Ana María, Ríos Susana, Fernández Mireya, Rodríguez J Pablo

机构信息

Laboratorio de Biología Celular, INTA, Universidad de Chile, Casilla 138-11, Santiago, Chile.

出版信息

J Cell Biochem. 2005 Jan 1;94(1):50-7. doi: 10.1002/jcb.20330.

DOI:10.1002/jcb.20330
PMID:15517602
Abstract

There are disparate observations on central and peripheral effects of leptin, but several studies consistently support its role as a link between fat and bone. Bone marrow stroma contains mesenchymal stem cells (MSCs), which differentiate into osteoblasts and adipocytes, among others. In this study we assessed the expression of leptin receptors protein in MSCs from control and osteoporotic postmenopausal donors and their change during osteogenic and adipogenic differentiation. Also, we assessed the effects of leptin on osteogenic and adipogenic differentiation of these cells. We demonstrated high affinity leptin binding (KD = 0.36 +/- 0.02 nM) in both types of cells. Binding was very low under basal, but increased significantly (2-3 times) through osteogenic and adipogenic differentiation. Osteoporotic MSCs showed lower leptin binding capacity than control cells at an early osteogenic and adipogenic differentiation time, which could restrict cell sensitivity to the protective action of leptin. In this regard, we observed that leptin significantly inhibited adipocyte differentiation in control but not in osteoporotic MSCs, while it exerted a low stimulatory effect on calcium deposition (10%-20%) in both types of MSCs cells. In summary, we report the presence of high affinity leptin receptors on control and osteoporotic MSCs, which were modified distinctly by osteogenic and adipogenic stimulation and a direct and distinct effect of leptin on both type of cells.

摘要

关于瘦素的中枢和外周作用存在不同的观察结果,但多项研究一致支持其作为脂肪与骨骼之间联系的作用。骨髓基质包含间充质干细胞(MSC),这些细胞可分化为成骨细胞和脂肪细胞等。在本研究中,我们评估了来自对照和绝经后骨质疏松症供体的MSC中瘦素受体蛋白的表达及其在成骨和成脂分化过程中的变化。此外,我们评估了瘦素对这些细胞成骨和成脂分化的影响。我们证明了两种类型的细胞中均存在高亲和力的瘦素结合(KD = 0.36 +/- 0.02 nM)。基础状态下结合力很低,但在成骨和成脂分化过程中显著增加(2 - 3倍)。在成骨和成脂分化早期,骨质疏松症的MSC显示出比对照细胞更低的瘦素结合能力,这可能会限制细胞对瘦素保护作用的敏感性。在这方面,我们观察到瘦素显著抑制对照MSC中的脂肪细胞分化,但对骨质疏松症的MSC没有作用,而它对两种类型的MSC细胞中的钙沉积均有低刺激作用(10% - 20%)。总之,我们报告了对照和骨质疏松症的MSC上存在高亲和力的瘦素受体,它们在成骨和成脂刺激下有明显改变,并且瘦素对两种类型的细胞有直接且明显的作用。

相似文献

1
High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors.高亲和力瘦素受体存在于源自对照和骨质疏松症供体的人间充质干细胞(MSC)中。
J Cell Biochem. 2005 Jan 1;94(1):50-7. doi: 10.1002/jcb.20330.
2
Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.骨质疏松症患者间充质干细胞(MSCs)的脂肪生成增加,其特征是瘦素作用受损。
J Cell Biochem. 2008 Mar 1;103(4):1054-65. doi: 10.1002/jcb.21516.
3
Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis.人骨髓间充质干细胞(MSCs)的成脂潜能与骨质疏松症的关系。
Curr Stem Cell Res Ther. 2008 Sep;3(3):208-18. doi: 10.2174/157488808785740325.
4
[Adipogenesis and osteoporosis].[脂肪生成与骨质疏松症]
Rev Med Chil. 2009 Jun;137(6):827-36. Epub 2009 Sep 4.
5
Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation.
J Cell Biochem. 2000 Sep 14;79(4):557-65. doi: 10.1002/1097-4644(20001215)79:4<557::aid-jcb40>3.0.co;2-h.
6
MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.MiR-27a对绝经后骨质疏松症中间充质干细胞从成骨分化向脂肪生成分化的转变至关重要。
Cell Physiol Biochem. 2016;39(1):253-65. doi: 10.1159/000445621. Epub 2016 Jun 24.
7
Vertebral Bone Marrow-Derived Mesenchymal Stromal Cells from Osteoporotic and Healthy Patients Possess Similar Differentiation Properties In Vitro.骨质疏松症和健康患者的椎骨骨髓间充质基质细胞在体外具有相似的分化特性。
Int J Mol Sci. 2020 Nov 5;21(21):8309. doi: 10.3390/ijms21218309.
8
Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women.来自对照和绝经后骨质疏松症女性的间充质干细胞中ERK1,2丝裂原活化蛋白激酶信号通路的差异激活。
J Cell Biochem. 2004 Jul 1;92(4):745-54. doi: 10.1002/jcb.20119.
9
Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.骨桥蛋白阳性细胞在骨质疏松患者骨髓间充质干细胞样细胞分化中的作用及对 Runx2 和 PPARγ2 表达的影响。
PLoS One. 2011;6(6):e20363. doi: 10.1371/journal.pone.0020363. Epub 2011 Jun 3.
10
Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.雌激素调节骨质疏松小鼠间充质干细胞(MSCs)中雌激素受体α和β的表达、成骨活性及细胞凋亡。
J Cell Biochem Suppl. 2001;Suppl 36:144-55. doi: 10.1002/jcb.1096.

引用本文的文献

1
Deficiency of Human Mesenchymal Stem Cells: Impact on Osteogenic, Chondrogenic, and Adipogenic Differentiation.人骨髓间充质干细胞缺乏:对成骨、成软骨和成脂分化的影响。
Int J Mol Sci. 2025 Jul 30;26(15):7363. doi: 10.3390/ijms26157363.
2
Cellular and molecular mechanisms underlying obesity in degenerative spine and joint diseases.退行性脊柱和关节疾病中肥胖的细胞与分子机制。
Bone Res. 2024 Dec 11;12(1):71. doi: 10.1038/s41413-024-00388-8.
3
Novel perspectives on leptin in osteoarthritis: Focus on aging.骨关节炎中瘦素的新视角:关注衰老。
Genes Dis. 2023 Nov 4;11(6):101159. doi: 10.1016/j.gendis.2023.101159. eCollection 2024 Nov.
4
Osteoporosis and Leptin: A Systematic Review.骨质疏松症与瘦素:一项系统综述。
Iran J Public Health. 2024 Jan;53(1):93-103. doi: 10.18502/ijph.v53i1.14686.
5
Adipokines at the crossroads of obesity and mesenchymal stem cell therapy.脂肪因子在肥胖症与间充质干细胞治疗的交叉点。
Exp Mol Med. 2023 Feb;55(2):313-324. doi: 10.1038/s12276-023-00940-2. Epub 2023 Feb 7.
6
Identification of a clinical signature predictive of differentiation fate of human bone marrow stromal cells.鉴定一种可预测人骨髓基质细胞分化命运的临床特征。
Stem Cell Res Ther. 2021 May 3;12(1):265. doi: 10.1186/s13287-021-02338-1.
7
Leptin acts on mesenchymal stem cells to promote chemoresistance in osteosarcoma cells.瘦素通过间充质干细胞作用促进骨肉瘤细胞的化疗耐药性。
Aging (Albany NY). 2020 Apr 14;12(7):6340-6351. doi: 10.18632/aging.103027.
8
The Analysis of Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45CD271 Phenotype.使用成纤维细胞集落形成单位检测法和CD45CD271表型对人骨髓间充质基质细胞衰老的分析
Stem Cells Int. 2019 Aug 1;2019:5197983. doi: 10.1155/2019/5197983. eCollection 2019.
9
Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway.低浓度氟灭酸通过抑制 NF-κB 信号通路增强间充质干细胞的成骨分化并抑制骨丢失。
Stem Cell Res Ther. 2019 Jul 19;10(1):213. doi: 10.1186/s13287-019-1321-y.
10
ΔFosB Requires Galanin, but not Leptin, to Increase Bone Mass via the Hypothalamus, but both are needed to increase Energy expenditure.Delta FosB 通过下丘脑增加骨量需要甘丙肽,但增加能量消耗需要瘦素。
J Bone Miner Res. 2019 Sep;34(9):1707-1720. doi: 10.1002/jbmr.3741. Epub 2019 Jul 30.